Tiszavasvári, Hungary

Agota Repasi

This inventor holds 1 USPTO granted patent. Top assignee: Alkaloida Vegyeszeti Gyar. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agota Repasi: Innovator in Pharmaceutical Preparations

Introduction

Agota Repasi is a notable inventor from Tiszavasvári, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release preparations. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to improving medication delivery systems.

Latest Patents

Agota Repasi holds a patent for a "Controlled release pharmaceutical preparation and process for preparing." This patent involves the preparation of controlled release pharmaceutical preparations by homogenizing various active substances, including opium alkaloids, their salts, and other medicinal compounds. The process also incorporates fatty acids and ethylene vinyl acetate copolymers to achieve a continuous phase transfer, enhancing the effectiveness of the pharmaceutical preparations.

Career Highlights

Throughout her career, Agota has demonstrated a commitment to advancing pharmaceutical science. She works at Alkaloida Vegyeszeti Gyar, where she collaborates with other talented professionals in the field. Her innovative approach to pharmaceutical formulations has positioned her as a key figure in her industry.

Collaborations

Agota has worked alongside esteemed colleagues such as Imre Gulyas and Jozsef Nagy. Their collaborative efforts have contributed to the success of various projects and have fostered a productive research environment.

Conclusion

Agota Repasi's contributions to the field of pharmaceuticals through her innovative patent and collaborative work highlight her importance as an inventor. Her dedication to improving medication delivery systems continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…